Connect Biopharma is trading 23.84% up in pre-market at $1.23 on September 30, with no company-specific announcement identified to explain the move.
- The September 29 close was $0.99; supplied price context shows a sharp rebound after an 8.15% decline in the prior session.
- September 15 was the latest company press release listed by investor relations.
- Broader-market indications were modestly mixed and do not clearly account for the gain.